The study identified RTN4IP1 as a factor associated with poor prognosis in triple-negative breast cancer, promoting metastasis through NAD⁺ depletion and disrupting glycolysis and oxidative phosphorylation. RTN4IP1 interacts with AK4 to cause this metabolic disruption.
Hepatic biliary adenofibroma (BAF) is a rare, benign tumor with histological characteristics distinct from other biliary tumors. Emerging case reports suggest potential for malignant transformation and overlap with intrahepatic cholangiocarcinoma (iCCA), highlighting diagnostic challenges and need for further research.
An international research team developed a user-friendly software method called Segment Anything for Microscopy, which can precisely segment images of tissues, cells, and similar structures. The new model improved performance for cell segmentation, enabling researchers to automate tasks that previously took weeks of manual effort.
Researchers at UCSF describe how to curb MYC levels by disrupting the protein assembly line controlled by RBM42. Disrupting RBM42 in pancreatic cancer cells stopped them from growing, suggesting drugs could be developed to do the same for other fast-growing cancers.
Researchers developed a novel microscopy technique to study metabolic changes in individual cancer cells at the single-cell level. They found that radiation treatment caused significant metabolic shifts in head and neck squamous cell carcinoma cells, particularly through the activation of HIF-1α.
A team led by biologist Thomas Mayer found that a small binding-pocket on cyclin B helps regulate the sequence of cell division events. Without this pocket, malformations occur due to incorrect kinase phosphorylation, leading to potential tumours or infertility.
A team of researchers has identified a mechanism that interferes with the splicing process in a more subtle way, leading to cell death. The study reveals that spliceosome subunits U4, U5, and U6 are normally stabilized by protein USP39, but when mutated or absent, stability is compromised, causing incorrect connections during splicing.
Scientists discover that multiciliated cells use cell division to control hair-like projections called cilia. This adaptation breaks the cancer-preventing rule of making only four centrioles per cell, producing hundreds instead.
A team of scientists studied the impact of radiation on DNA, revealing that damaged areas are separated by a critical distance before breaking. The study found an exponential increase in DNA breakage time with distance, providing crucial information for effective DNA repair processes.
Cancer-associated fibroblasts (CAFs) are a type of cell that plays a crucial role in the tumor microenvironment. The authors suggest that understanding CAFs is essential for developing effective cancer therapies. Research targeting CAFs has shown promise, but challenges remain due to their complex nature.
Researchers at the University of Missouri have successfully used click chemistry to deliver radiopharmaceuticals specifically to tumors in large dogs with bone cancer, increasing effectiveness and minimizing circulation. This breakthrough could pave the way for click chemistry-based treatments for humans with cancer in the future.
Researchers propose an optical imaging system for real-time hypoxia imaging in cancer treatment. The technique utilizes protoporphyrin IX to enhance contrast between tumors and healthy tissues, allowing for more effective surgical removal.
Researchers developed an AI system that classifies IBDN lesions accurately, displaying image-based diagnostic ability with 64.5% sensitivity and 89.5% specificity. The correct diagnosis rate of the AI system was 79.0, surpassing that of endoscopists, who achieved a 77.8% accuracy rate.
Researchers from Kazan Federal University have developed a gene-cell preparation that uses membrane vesicles to target and kill cancer cells. The technology has shown promise in treating various types of cancer, including breast, lung, and colon cancer.
Researchers identified a critical phosphorylation process in PHD2 that slows down cancer growth. Blocking the enzyme PP2A/B55 restores PHD2 function, suggesting a promising new approach for targeted cancer therapy.
Researchers at Indiana University identify a molecular 'switch' in clathrin that may play a role in suppressing tumors. The discovery could lead to new strategies for controlling cancer.
Scientists at The Wistar Institute identified a new gene called chfr that establishes a previously unknown checkpoint in mitosis, found in half of human cancer cell lines. This discovery holds promise for predicting patient response to Taxol and developing more effective targeted drugs.
A study by Johns Hopkins Medicine reveals that nearly 90% of prostate cancers are linked to a common genetic process called 'gene switching,' which can be reversed with drugs. This finding has the potential to correct one of the most common cancers in men without using typical gene therapy.
A new technique called laser capture microdissection enables researchers to extract and analyze small clusters of cells from tissue samples in as little as eight seconds. This allows for immediate analysis of gene and enzyme activity, revolutionizing the understanding of cancer's molecular basis.
Researchers from Emory University and UCLA identified a brain region responsible for recalibrating eye-hand coordination in response to visual distortions. The posterior parietal cortex area PEG was found to be selectively activated during the process, suggesting its role in visuomotor recalibration.